SCHEMBL6715500

SCHEMBL6715500

COc1ccc(-c2cccc3cc4n(c23)CCNCC4)c(C(C)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.45
HTR2A P28223 6/20 0.44
HTR2C P28335 6/20 0.44
ADRB1 P08588 1/20 0.37
ABCB1 P08183 1/20 0.36
GRM5 P41594 1/20 0.35
GRM1 Q13255 1/20 0.35
HTR1A P08908 2/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
HTR7 P34969 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6719339 0.89 HTR2A (0.44) PARP1HTR2AHTR2CADRB1ABCB1
SCHEMBL6715823 0.84 HTR2A (0.48) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6714232 0.84 HTR2A (0.54) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6713716 0.84 HTR2A (0.48) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6714255 0.83 HTR2A (0.47) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6713842 0.83 HTR2A (0.49) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6711697 0.83 HTR2A (0.45) PARP1HTR2AHTR2CADRB1ABCB1
SCHEMBL6713702 0.83 HTR2A (0.45) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6714086 0.83 HTR2A (0.45) PARP1HTR2AHTR2CADRB1HTR1A
SCHEMBL6713854 0.82 HTR2A (0.41) PARP1HTR2AHTR2CADRB1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds ENNIS MICHAEL DALTON (US) 2004-10-21 US disclosed
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds PHARMACIA & UPJOHN COMPANY 2002-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HTR1D, HTR1A, HTR1E PARP1 1281/4885HTR2A 18/4885HTR2C 7/4885
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HCRTR2, NR2C2, RCOR3 PARP1 1140/4885HTR2A 1403/4885HTR2C 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.